Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells-the second neuro map designed to accelerate treatments for a wide range of ...

More cases and deaths in new states have been detected over the past month, health officials report. A deadly outbreak of ...

Mirum Pharmaceuticals, Inc. today reported financial results for the third quarter 2025 and provided a business update. "Mirum is well positioned heading into 2026 with strong commercial momentum and ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...